Drug ID: | NPD1783 |
Drug Name: | |
Molecular Formula: | C15H23N3O4 |
Canonical SMILES: | COCCCNC(=O)c1nccc(c1)C(=NCCCOC)O |
Standard InCHI: | InChI=1S/C15H23N3O4/c1-21-9-3-6-17-14(19)12-5-8-16-13(11-12)15(20)18-7-4-10-22-2/h5,8,11H,3-4,6-7,9-10H2,1-2H3,(H,17,19)(H,18,20) |
Standard InCHIKey: | HLSXICGBWKECLM-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB014008 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 309.17 |
ALogP | -1.5738 |
MLogP | 2.34 |
XLogP | 0.596 |
HDA | 7 |
HBD | 2 |
Rotatable Bonds | 14 |
TPSA | 93.04 |
RO5 Violation | 1 |